iShares Nasdaq Biotechnology ETF (IBB)

131.78
Delayed Data
As of 4:36pm ET
 -3.09 / -2.29%
Today’s Change
92.15
Today|||52-Week Range
146.53
+9.35%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Biotech Bonanza - Second Half Outlook
Jul 28 / Seeking Alpha - Paid Partner Content
 

Performance

1 month-2.78% 3 years+9.05%
3 months+7.09% 5 years+2.30%
1 year+31.31% Since inception+7.65%
Data through 08/08/2020

Quote Details

Previous close$134.87
Open day’s range131.68 – 134.62
Net asset value (NAV)136.24 (08/07/2020)
Daily volume223,176
Average volume (3 months)3,447,480
Data as of 4:36pm ET, 08/11/2020

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+2.30%+6.57%
Expense Gross exp ratio0.47%1.22%
Risk 5 year sharpe ratio0.130.37
Net assets$9.7B$3.5B
Average market cap$17.1B$40.8B
Average P/E24.127.0
Dividend / Share--0.28%

Competitors

VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
XHE SPDR® S&P Health Care Equipment ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen8.50%
VRTX Vertex Pharmaceuticals Inc7.47%
GILD Gilead Sciences7.13%
REGN Regeneron Pharmaceuticals6.75%
ILMN Illumina Inc5.95%
BIIB Biogen3.57%
MRNA Moderna Inc3.12%
SGEN Seattle Genetics Inc3.12%
ALXN Alexion Pharmaceuticals Inc2.45%
BMRN Biomarin Pharmaceutical Inc2.35%